Medpace Holdings, Inc.
MEDP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $659,903 | $603,311 | $558,570 | $536,589 |
| % Growth | 9.4% | 8% | 4.1% | – |
| Cost of Goods Sold | $462,964 | $423,298 | $380,220 | $358,272 |
| Gross Profit | $196,939 | $180,013 | $178,350 | $178,317 |
| % Margin | 29.8% | 29.8% | 31.9% | 33.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $43,933 |
| SG&A Expenses | $48,082 | $46,664 | $57,897 | $45,433 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1,500 |
| Other Operating Expenses | $7,049 | $7,014 | $6,930 | $7,506 |
| Operating Expenses | $55,131 | $53,678 | $64,827 | $52,939 |
| Operating Income | $141,808 | $126,335 | $113,523 | $125,378 |
| % Margin | 21.5% | 20.9% | 20.3% | 23.4% |
| Other Income/Exp. Net | $1,028 | -$1,797 | $4,647 | $8,504 |
| Pre-Tax Income | $142,836 | $124,538 | $118,170 | $133,882 |
| Tax Expense | $31,701 | $34,278 | $3,575 | $16,864 |
| Net Income | $111,135 | $90,260 | $114,595 | $117,018 |
| % Margin | 16.8% | 15% | 20.5% | 21.8% |
| EPS | 3.95 | 3.16 | 3.77 | 3.78 |
| % Growth | 25% | -16.2% | -0.3% | – |
| EPS Diluted | 3.87 | 3.1 | 3.67 | 3.67 |
| Weighted Avg Shares Out | 29,033 | 29,489 | 30,387 | 30,945 |
| Weighted Avg Shares Out Dil | 29,710 | 30,165 | 31,196 | 32,014 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,517 | $1,078 | $6,463 | $7,883 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $7,049 | -$6,930 | $6,930 | $7,506 |
| EBITDA | $149,885 | $117,608 | $120,453 | $132,884 |
| % Margin | 22.7% | 19.5% | 21.6% | 24.8% |